Step 2 of 8
Chronic Mental Illness in a Treated World
By the end of this lesson you will understand why diagnoses and prescriptions for common mental health conditions have risen sharply while population-level well-being has not improved in step, and you will be able to name the specific cognitive, clinical and systemic mechanisms that produce that paradox.
More people than ever have a name for what they are going through, and more people than ever are being treated for it. On paper, that should have moved the needle on suffering. This lesson looks carefully at why it largely has not, and what that gap tells us about the models we have been working from.
Imagine a smoke detector that has been recalibrated to be more sensitive. The intention is entirely sound: the old one missed a real fire, so the threshold was lowered. Now it catches smoke earlier, which is genuinely valuable. It also goes off when you make toast, when the shower runs hot, when someone lights a candle. Nothing about the building has changed. The rate of alarms has changed. If you only counted alarms, you would conclude the house had become dangerous.
Something structurally similar has happened in psychiatry over the past four decades. As the field sought greater scientific rigor, the Diagnostic and Statistical Manual became more granular and more explicit about what counted as a disorder. The aim was precision. One consequence was a lowered threshold, particularly for major depressive disorder, generalized anxiety disorder and adult attention deficit disorder. When the description of suffering becomes more inclusive, more people accurately recognize themselves in it. This is not fraud on anyone's part. It is the predictable arithmetic of moving a boundary.
A second mechanism operates in the reader's own mind rather than in the manual. Cognitive scientists call it the availability heuristic: we judge how likely something is by how easily examples come to mind. Public awareness campaigns, pharmaceutical advertising and an internet saturated with symptom checklists make diagnostic language extraordinarily easy to retrieve. When you feel flat for three weeks, the word depression is now closer to hand than the words grief, exhaustion or a bad stretch. That accessibility shapes what you report to a clinician, which shapes what the clinician hears, which shapes the outcome of a ten-minute appointment.
The screening tools used in primary care sit right at that intersection. They are short inventories designed to reduce missed cases, and they do reduce missed cases. But they are also state-dependent. Answering them after a fortnight of poor sleep, a difficult project and a family conflict produces a different score than answering them a month later, because of what psychologists call recall bias and salience: recent, emotionally vivid experience dominates the sample your memory offers up. A brief and self-limiting period of distress can therefore set in motion something durable, since guidelines often recommend pharmacologic treatment for a moderate or severe positive screen.
What makes that durable rather than temporary is path dependency. Once a diagnosis exists in a record and a medication has been started, continuing is the low-friction option for everyone involved. Discontinuation carries real risk and requires time and monitoring that a rushed system rarely has. Insurance reimbursement may depend on a documented diagnosis. Appointments become prescription check-ins rather than reappraisals. Over years, an episode can quietly harden into an identity, not because anyone decided it should, but because no part of the system was designed to ask the question again.
You can watch these mechanisms interact in ordinary working life. A demanding quarter erodes sleep. Notifications fragment attention so thoroughly that focused work feels impossible, which is exactly what chronic cognitive load does to executive function. Motivation drops, irritability rises, the weekend stops restoring anything. That constellation is real and worth taking seriously. It also maps neatly onto two or three diagnostic categories, and the path from there to a prescription is short, well-lit and socially sanctioned.
Three misreadings are worth heading off. The first is to conclude that mental illness is therefore overstated. It is not. Severe depression, bipolar illness and psychotic disorders are devastating, and for these, medication is often the difference between a life and no life at all. The second is the mirror image: assuming medication is straightforwardly effective across the board. Meta-analyses consistently show meaningful benefit in severe and clearly defined presentations, and a much more modest separation from placebo in mild to moderate distress, with population remission rates that remain stubbornly low. The third is the private, unsupervised experiment. Nothing in this lesson is an argument for changing or stopping treatment on your own; withdrawal effects and relapse are real, and any reappraisal belongs in a conversation with the clinician who knows your history.
Here is the observation that should unsettle us. If the primary problem were underdiagnosis and undertreatment, then four decades of broader criteria, better awareness and vastly expanded prescribing should have produced a visible fall in psychiatric disability. It has not. Prevalence and disability have held steady or risen. That result is not a verdict on any individual's treatment, and it is not evidence that anyone acted badly. It is a signal about the model itself. When effort scales dramatically and outcomes do not follow, the most likely explanation is that something upstream of the model is being missed.
Key points
- Broadened diagnostic criteria in successive editions of the DSM lowered the threshold for several common disorders, which increases diagnosis rates without any change in the underlying population.
- Constant cultural exposure to psychiatric vocabulary makes diagnostic explanations cognitively easier to reach for than situational ones, shaping what people report and what clinicians hear.
- Brief screening tools are sensitive to recent sleep, stress and mood, so a difficult fortnight can generate a positive screen that leads to a lasting diagnosis and prescription.
- Path dependency and clinical inertia mean established treatments are far more likely to be continued than systematically reappraised, partly for sound safety reasons and partly for systemic ones.
- Medication shows clear benefit for severe and well-defined presentations, while the separation from placebo in mild to moderate distress is modest and population remission rates remain low.
- Decades of expanded diagnosis and treatment have not produced a proportionate reduction in psychiatric disability, which points to a gap in the underlying model rather than a failure of effort.
Do this before the next step
For one week, record mood, energy, sleep and focus in plain descriptive language rather than diagnostic labels, and note alongside each entry what the day actually contained: hours slept, workload, alcohol, meals, daylight, conflict. This works because it separates the signal from the story. Diagnostic categories compress a great deal of information into a single word, and once that word is applied, the underlying pattern becomes harder to see.
Before your next appointment, write a short timeline of when things changed and what else changed at the same time. Clinicians working in ten-minute slots depend heavily on what you bring them, and a timeline gives them context that a symptom checklist structurally cannot capture. It also protects against recall bias, because you are reconstructing the sequence deliberately rather than reporting whichever weeks happen to be most vivid.
Notice how you narrate a difficult week to yourself, specifically whether you describe the state as something passing through you or something you are. Explanatory style measurably influences help-seeking, expectation and recovery. This is not about denying real difficulty or talking yourself out of care; it is about keeping both interpretations available so that a temporary state is not automatically filed as a permanent trait.
Answer these honestly
- Thinking about yourself or people close to you, has greater awareness and easier access to mental health care translated into sustained improvement, or into more names and more treatments with roughly the same lived experience?
- If you have carried a diagnosis or a prescription for some time, when was the last occasion anyone revisited the original reasoning rather than reviewing symptoms and refilling?
- Which of your current difficulties with mood, energy or attention might be tracking something in your circumstances, your sleep or your physiology that a symptom checklist would never have asked about?